UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 14, 2016
Accession Number: 0001469709-16-000716
Submission Type: POS AM
CIK: 0001528172
Company Name: ENDONOVO THERAPEUTICS, INC.
File Number: 333-202068